NCT07070804

Brief Summary

This study will recruit nuMoM2b participants to complete autism screening surveys and will identify 200 children with autism and 400 controls for the study. It will then use existing biospecimens to measure pesticides in maternal urine and metabolomic urine and cord blood predictors of autism risk. All data will then be used to build a predictive model for autism risk at the child's birth.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
24mo left

Started Sep 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

July 17, 2025

Completed
1.1 years until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2028

Last Updated

November 21, 2025

Status Verified

November 1, 2025

Enrollment Period

2 years

First QC Date

June 27, 2025

Last Update Submit

November 18, 2025

Conditions

Keywords

nuMoM2bautismprediction

Outcome Measures

Primary Outcomes (1)

  • Diagnosis of autims

    Autism diagnoses will be made using the Autism Diagnostic Inventory on all children who screen positive. Alternatively, if already diagnosed clinically, we will request the diagnostic tool used previously for the child.

    The children are age 11-14 currently. The outcome will be measured during contact with the children in the first 18 months of the project.

Interventions

No interventions performed

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

children of nuMoM2b cohort

You may qualify if:

  • child of nuMoM2b study participant

You may not qualify if:

  • no biological samples collected during pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

urine for future use

MeSH Terms

Conditions

Autistic Disorder

Condition Hierarchy (Ancestors)

Autism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

June 27, 2025

First Posted

July 17, 2025

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

August 30, 2028

Study Completion (Estimated)

August 30, 2028

Last Updated

November 21, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

deidentified data upon request per NIH guidance

Shared Documents
STUDY PROTOCOL
Time Frame
After study completion